...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

"Agoracom should change the info they have under "Fast Facts" as well."

I changed the symbol to "None" and the exchange to "Private".

Share
New Message
Please login to post a reply